Genedata Bioprocess® has been rapidly adopted by leading biopharmas and CMOs with collaborations that range from single group installations to multi-site partnerships and include technology transfer, customizations, training, and deployment support.
Sartorius Stedim Increases Productivity 3X
Learn why Sartorius Stedim, a global leader in bioprocess development, implemented Genedata Bioprocess to fully digitalize their laboratory workflows. As Sartorius moved from spreadsheets to automated data handling, they were able to streamline and automate their bioprocess development operations thanks to Genedata’s built-in capabilities. This resulted in a threefold increase in overall productivity.
Meet the Genedata Community
Genedata Biopharma Partner Symposium March 23–24, 2022 | Basel, Switzerland
The Genedata Biologics Partner Symposium is a unique interdisciplinary event at the interface between biopharma R&D and IT is your chance to learn how other companies have set up and are using Genedata platforms. Presentations and discussions will focus on innovative applications and new industry requirements, such as novel molecular formats (e.g., multispecifics, TCRs, and AAVs) and increasing automation and standardization in biopharmaceutical R&D. Leading biopharma companies will show how groups have set up, operate, and use Genedata platforms to transform their biotherapeutics research & development and how this results in increased efficiency and throughput.
Genedata's customers at leading biopharmaceutical and biotech companies worldwide regularly present how Genedata Bioprocess is used to advance their R&D activities. Learn how Pfizer, Bayer, Sanofi, Celgene and others are streamlining processes and increasing the efficiency of their biotherapeutic development operations with the Genedata platform.
“As a fully integrated end-to-end platform, Genedata Bioprocess integrates data capture, analysis, and reporting across all of our bioprocess development operations and serves as our central data backbone to ensure data integrity and compliance.”
Direct Lab Integration with Genedata Bioprocess
“Our decision to adopt the Genedata Bioprocess platform is based on its ability to directly integrate with our laboratory equipment and automate all data transfer, capture, processing, and data analysis and interpretation."
Genedata Enables Data-Informed Decisions
“To support our vision of transforming cancer treatment, we are excited to implement the Genedata Biopharma Platform as a central integrated data backbone to streamline the capture, integration, democratization, and analysis of increasingly complex and diverse data types."
Flexible Business Model Works for SMEs
"Thanks to Genedata’s flexible business model, we are able to take advantage of Genedata’s unique technology under terms that work well for a company of our size."
Increasing Automation and Operational Efficiency
“We aimed to extend automation and further enhance the efficiency of our cell line, upstream and bioanalytical development operations, and quickly realized that Genedata Bioprocess addresses many of our requirements off-the-shelf, eliminating the need for expensive customization."
Pfizer Builds on Genedata E2E Platform
"After conducting a pilot project to determine if Genedata Bioprocess had the potential to meet our requirements, we decided to move forward with its implementation.”
Scalable Informatics Infrastructure
"We appreciate the collaborative approach with Genedata, and their unique expertise in biopharma discovery and process optimization."
Increasing Efficiency in Biologics R&D
"The Biologics Data Platform makes the highly interconnected biologics R&D processes more efficient."